- U.K. company formed in
1997 to develop mycological and herbal products, with initial
focus being in the mycology sector...objective to gain general
acceptance of mycology as an adjuvant nutritional therapy.
|
- MRL founders had previously
initiated and developed the first controlled cultivation of Shiitake
Mushrooms in North America.
|
- Up until MRL's entry
into the marketplace most research in mycology in the treatment
of immune disorder existed mostly in Japan and China.
|
- Both Japanese and Chinese
medical establishments accept mycology in treatment of immune
related disorders due to the 'action' of the fungi - unlike Western
medicine which seeks to isolate the active ingredient and thus
determine the 'mechanism of action'.
|
- Research / clinical trails
are being conducted in the U.K., U.S., Spain, Portugal, Italy,
Holland and Germany.
|
- Both medical and natural
health practitioners involvement
|
- Initial research weighted
towards Coriolus and Cordyceps
|
- Veterinary research underway
in U.K.
|
- Product grouping that
has been formulated to be safe in toxicity levels and to meet
the needs of specific health challenges, as well as, improve
and supplement general body health
|
